CAS: 432529-82-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | BCI-121 REF: IN-DA01EO5YCAS: 432529-82-3 | 98% | To inquire | Tue 07 Jan 25 |
 | BCI-121 REF: 54-BISN0081CAS: 432529-82-3 | 99% | 152.00 €~1,237.00 € | Tue 14 Jan 25 |
 | BCI-121 REF: TM-T5322CAS: 432529-82-3 | 99.67% | 35.00 €~467.00 € | Tue 14 Jan 25 |
 | BCI-121 REF: 3D-HSA52982CAS: 432529-82-3 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: IN-DA01EO5Y
| 1g | To inquire | ||
| 100mg | 194.00 € | ||
| 250mg | 499.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 54-BISN0081
| 1g | 1,237.00 € | ||
| 100mg | 272.00 € | ||
| 250mg | 477.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
BCI-121
CAS:432529-82-3
BCI-121 is a substrate-competitive SMYD3 inhibitor that inhibits the proliferation of the cancer cell.
Formula:
C14H18BrN3O2
Purity:
99.67%
Color and Shape:
Solid
Molecular weight:
340.22
Ref: TM-T5322
| 1mg | 35.00 € | ||
| 5mg | 65.00 € | ||
| 10mg | 96.00 € | ||
| 25mg | 185.00 € | ||
| 50mg | 294.00 € | ||
| 100mg | 467.00 € | ||
| 1mL*10mM (DMSO) | 72.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
BCI-121
CAS:432529-82-3
BCI-121 is an investigational drug that inhibits the enzyme lysine methyltransferase (KMT), which is involved …
Formula:
C14H18BrN3O2
Purity:
Min. 95%
Molecular weight:
340.22 g/mol
Ref: 3D-HSA52982
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
